I-Che Feng
Overview
Explore the profile of I-Che Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang C, Wei S, Shieh M, Chou J, Chuang C, Wang H, et al.
J Formos Med Assoc
. 2025 Feb;
PMID: 39893095
Background: Despite industrialization and advances in healthcare, the prevalence of inflammatory bowel disease (IBD), which encompasses Crohn's disease (CD) and ulcerative colitis (UC), is increasing in Taiwan. Population-based studies can...
2.
Wu H, Weng M, Chou J, Yen H, Lin C, Chiang F, et al.
Clin Transl Gastroenterol
. 2024 Dec;
16(2):e00798.
PMID: 39636008
Introduction: We explored the clinical characteristics, treatment, and outcomes of colitis-associated colorectal cancer (CAC) and compared with sporadic colorectal cancer in Taiwan. Methods: In this retrospective study spanning 1987-2022, CACs...
3.
Chen Y, Yang C, Kuo H, Sheu M, Feng I, Liu C, et al.
Int J Med Sci
. 2024 Jul;
21(9):1661-1671.
PMID: 39006848
Patients with chronic hepatitis B patients (CHB) with low-level viremia (LLV) are not necessarily at low risk of developing hepatocellular carcinoma (HCC). The question of whether CHB patients with LLV...
4.
Chang H, Wang S, Kuo H, Sheu M, Feng I, Ho C, et al.
Int J Hepatol
. 2024 Mar;
2024:3184892.
PMID: 38510786
We aimed to analyze the different patient characteristics and treatment outcomes (such as sustained viral response, SVR) between incarcerated patients with chronic hepatitis C (CHC) and those with CHC from...
5.
Yang C, Chen J, Chang H, Sheu M, Feng I, Wang S, et al.
Case Rep Gastroenterol
. 2024 Mar;
18(1):136-143.
PMID: 38501149
Introduction: Syphilis, an ancient sexually transmitted disease, is recognized as a systemic infection disease manifesting with diverse symptoms and variations. Secondary syphilis characterized by systemic symptoms resulted from hematogenous and...
6.
Wu P, Feng I, Lai C, Ho C, Kan W, Sheu M, et al.
PeerJ
. 2023 Dec;
11:e16582.
PMID: 38077441
Background: Patients with chronic liver disease (CLD) have a higher risk of mortality when infected with severe acute respiratory syndrome coronavirus 2. Although the fibrosis-4 (FIB-4) index, aspartate aminotransferase-to-platelet ratio...
7.
Cheng P, Sun H, Feng I, Wang S, Chiu Y, Chiu H, et al.
J Virus Erad
. 2023 Apr;
9(1):100318.
PMID: 37065432
Introduction: Hepatitis C (HCV) is associated with extra-hepatic involvment, morbidity as well as metabolic changes. Whether these might be reversible if sustained virologic response (SVR) is achieved by direct-acting antiviral...
8.
Lin W, Tai W, Chang C, Tu C, Feng I, Shieh M, et al.
Inflamm Bowel Dis
. 2023 Jan;
29(11):1730-1740.
PMID: 36626567
Background: This nationwide prospective registry study investigated the real-world effectiveness, safety, and persistence of vedolizumab (VDZ) in inflammatory bowel disease (IBD) patients in Taiwan. Disease relapse rates after VDZ discontinuation...
9.
Wu P, Sun C, Kuo H, Sheu M, Lin C, Wang S, et al.
J Med Case Rep
. 2022 Nov;
16(1):424.
PMID: 36336687
Background: Kaposi sarcoma is a vascular tumor highly related to human herpesvirus-8 and Kaposi sarcoma-associated herpesvirus. Kaposi sarcoma usually manifests as skin or mucosal lesions; involvement in visceral organs such...
10.
Cheng P, Sun H, Feng I, Chiu Y, Wang S, Tan D, et al.
J Microbiol Immunol Infect
. 2022 Jul;
56(1):20-30.
PMID: 35842406
Background: Chronic hepatitis C virus (HCV) infection causes various liver diseases and metabolic disorders. With direct-acting antiviral agents (DAAs), which effectively eradicate pan-genotypic HCV, hepatic and concomitant metabolic restorations are...